- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02526576
Adipose Derived Stem Cells in Facial Fat Grafting (SVF)
A Phase II Double-blind, Randomized, Study to Assess the Efficacy of Facial Fat Grafts Supplemented With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Human Adipose Tissue is considered as a new source for Stromal Stem Cells and offers a large therapeutic potential for many rare and common diseases that impacts millions of patients worldwide. The Stromal Vascular Fraction (SVF) of Adipose Tissue is relatively easy to extract with minimally invasive procedures such as elective liposuction in large quantities and therefore may be a cost effective source for cellular therapies in a wide range of medical specialties.
The term "Facial Atrophy" describes the lost of subcutaneous fat within the face and can be a result of the aging process as well as some pathological diseases. It can be corrected via autologous fat transfer but usually the majority of the grafted cells will die after 6-12 months. Several publications demonstrate that the addition of SVF cells to the graft may enhance the graft survival.
This double blind, randomized study aims to demonstrated the efficacy of Antria Cell Preparation Process in autologous facial fat grafting.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Delmont, Pennsylvania, United States, 15601
- Delmont Surgery Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female or Male, Age 18 to 70 years old
- Subjects that are eligible for liposuction and facial fat grafting procedures for cosmetic purposes and facial atrophy.
- Subjects must require augmentation to the infra-malar region. Furthermore, facial engraftment to additional, non-study related regions is optional, but not required.
- Inframalar Atrophy Assessment Scale of 2 to 4
- Facial volume defect range: 2 to 10 mL
- Body Mass Index (BMI) between and including 22 and 29
- Able to understand and provide written and verbal informed consent
- Fitzpatrick Scale 1 to 6
Exclusion Criteria:
- Currently taking or have taken None Steroid Anti-inflammatory Drugs (NSAIDs) within last two weeks or corticosteroids within the last six weeks prior to screening
Diagnosis of any of the following medical conditions:
- Active malignancy (diagnosed within 5 years), except for treated non-melanoma skin cancer or other non-invasive or in-situ neoplasm (e.g. cervical cancer)
- Active infection
- Type I or Type II Diabetes
- Skin/Bone deformities in the face, including scaring or hyperpigmentation within the graft site.
- Subjects who are unlikely to comply with the protocol (e.g., uncooperative attitude, inability to return for subsequent visits, dementia, and/or otherwise considered by the Investigator to be unlikely to complete the study)
- Subjects with a known drug or alcohol dependence within the past 12 months as judged by the Investigator
- Dermal fillers or facial reconstruction within the past 24 months, Subjects must also refrain from such procedures during the duration of the study.
- Subjects with major illnesses involving the renal, hepatic, cardiovascular, and/or nervous systems.
- Subjects with elevated kidney and/or liver functions
- Any other disease condition or laboratory results that in the opinion of the investigator may be clinically significant and render the subject inappropriate for the study procedure(s), may alter the accuracy of study results, or increase risk for subjects.
- Subjects with life-expectancies less than 9 months
- Subjects with known collagenase allergies
- Subjects with idiopathic or drug-induced coagulopathy
- Pregnant females
- On radiotherapy or chemotherapy agents
- Taking strong CYP450 inhibitors
- Subjects with a history of keloids or hypertrophic scar formations
- Previous treatment with any synthetic fillers in the inframalar area
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Stromal Vascular Fraction
Subjects will receive stromal vascular fraction assisted fat transfer.
|
The stromal vascular fraction obtained from adipose tissue will be added to the graft
Other Names:
A subgroup of each arm (2 subjects from each arm) will undergo a fat transfer behind each ear to be removed via biopsy after 12 months
|
ACTIVE_COMPARATOR: Biopsy for Control -regular fat transfer
Subjects will receive regular fat transfer.
A biopsy procedure will analyzes the different between experimental and control groups.
|
A subgroup of each arm (2 subjects from each arm) will undergo a fat transfer behind each ear to be removed via biopsy after 12 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Volume retention
Time Frame: 12 months
|
To demonstrate that SVF administration, in concert with autologous facial fat grafts, is more efficacious, with regards to graft survival, than standard, non-SVF enhanced, autologous facial fat grafts
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants ith autologous facial fat grafts via laboratory results
Time Frame: 36 months
|
To monitor the safety of SVF administration along with autologous facial fat grafts via laboratory results
|
36 months
|
Changes in the quality of skin
Time Frame: 12 months
|
a blinded and independent investigator will assess any changes to the quality of skin
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Shahram Rahimian, MD, Antria
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SSVF0002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Facial Atrophy
-
The Cleveland ClinicWithdrawnFacial Atrophy Related to Age
-
Universidade Metropolitana de SantosCompletedFacial Expression | Bichat's Fat Pad AtrophyBrazil
-
Syntr Health Technologies, Inc.Active, not recruitingFacial Atrophy and Loss of ContourUnited States
-
Adipeau Inc.Romo Plastic SurgeryRecruitingPhotoaging | Atrophy, Hemifacial | ElastosisUnited States
-
R-BioAsan Medical CenterCompletedRomberg's Disease | Progressive Hemifacial AtrophyKorea, Republic of
-
Sun Yat-sen UniversityUnknownEye Injuries | Retina Detachment | Eye Atrophy | Silicone EmulsionChina
-
AbbVieCompletedFacial Corrections | Facial LinesAustralia, Belgium
-
University of PittsburghRecruiting
-
Northwestern UniversityCompletedAtypical Facial Pain | Typical Facial PainUnited States
-
University of UtahCompletedSynkinesis | Facial Asymmetry | Facial Nerve Injuries | Facial Paresis Associated With Facial Nerve Dysfunction
Clinical Trials on Stromal Vasular Fraction
-
Makerere UniversityCompletedFeasibility | Keloid | Safety | Autologus Adipose Derived Stem CellsUganda
-
Robert W Alexander, MDRegeneris Medical; Global Alliance for Regenerative MedicineUnknownOsteoarthritis | Back Pain | Tendinopathy | Tendinosis | Degenerative Joint Disease | Rheumatoid NoduleUnited States
-
Kasiak Research Pvt. Ltd.UnknownCritical Limb IschemiaIndia
-
Sohag UniversityNot yet recruitingAndrogenic Alopecia
-
Xijing HospitalRecruiting
-
Hospital of South West JutlandOdense University HospitalActive, not recruiting
-
Mayo ClinicWithdrawnBronchoesophageal Fistula | Tracheoesophageal Fistula | Tracheoesopharyngeal FistulaUnited States
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Istituto Ortopedico RizzoliActive, not recruitingTendinopathy | Patellar Tendinopathy | Patellar TendinitisItaly